AU6648094A - Transdermal therapeutic systems for the administration of serotonin agonists - Google Patents

Transdermal therapeutic systems for the administration of serotonin agonists

Info

Publication number
AU6648094A
AU6648094A AU66480/94A AU6648094A AU6648094A AU 6648094 A AU6648094 A AU 6648094A AU 66480/94 A AU66480/94 A AU 66480/94A AU 6648094 A AU6648094 A AU 6648094A AU 6648094 A AU6648094 A AU 6648094A
Authority
AU
Australia
Prior art keywords
administration
transdermal therapeutic
therapeutic systems
serotonin agonists
active substances
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU66480/94A
Other versions
AU686159B2 (en
Inventor
Harald List
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTS Lohmann Therapie Systeme AG
Original Assignee
LTS Lohmann Therapie Systeme AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LTS Lohmann Therapie Systeme AG filed Critical LTS Lohmann Therapie Systeme AG
Publication of AU6648094A publication Critical patent/AU6648094A/en
Assigned to LTS LOHMANN THERAPIE-SYSTEME GMBH reassignment LTS LOHMANN THERAPIE-SYSTEME GMBH Amend patent request/document other than specification (104) Assignors: LTS LOHMANN THERAPIE-SYSTEME GMBH & CO. KG
Application granted granted Critical
Publication of AU686159B2 publication Critical patent/AU686159B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention concerns a transdermal therapeutic system for the systemic administration of active substances, the system being characterized in that at least one of the active substances is a serotonin agonist selected from the indole derivatives, e.g. sumatriptan.
AU66480/94A 1993-05-06 1994-04-25 Transdermal therapeutic systems for the administration of serotonin agonists Ceased AU686159B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4314976 1993-05-06
DE4314976A DE4314976C1 (en) 1993-05-06 1993-05-06 Transdermal therapeutic systems for the administration of drugs, process for their production and their use
PCT/EP1994/001280 WO1994026270A1 (en) 1993-05-06 1994-04-25 Transdermal therapeutic systems for the administration of serotonin agonists

Publications (2)

Publication Number Publication Date
AU6648094A true AU6648094A (en) 1994-12-12
AU686159B2 AU686159B2 (en) 1998-02-05

Family

ID=6487316

Family Applications (1)

Application Number Title Priority Date Filing Date
AU66480/94A Ceased AU686159B2 (en) 1993-05-06 1994-04-25 Transdermal therapeutic systems for the administration of serotonin agonists

Country Status (20)

Country Link
EP (1) EP0697869B1 (en)
JP (1) JPH08509749A (en)
KR (1) KR960702306A (en)
AT (1) ATE183392T1 (en)
AU (1) AU686159B2 (en)
CA (1) CA2160776A1 (en)
CZ (1) CZ289395A3 (en)
DE (2) DE4314976C1 (en)
DK (1) DK0697869T3 (en)
ES (1) ES2138659T3 (en)
FI (1) FI955260A (en)
GR (1) GR3031639T3 (en)
HU (1) HUT74865A (en)
IL (1) IL109509A (en)
NO (1) NO954414D0 (en)
NZ (1) NZ265949A (en)
PL (1) PL179353B1 (en)
SK (1) SK138095A3 (en)
WO (1) WO1994026270A1 (en)
ZA (1) ZA942872B (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9509985A (en) 1995-12-12 1998-11-03 Omeros Med Sys Inc Solution for irrigation and method for inhibiting pain, inflammation and sparse
US8022095B2 (en) 1996-08-16 2011-09-20 Pozen, Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
EP1170006B8 (en) * 1999-12-14 2008-03-19 Teikoku Seiyaku Co., Ltd. Drug for alleviating migraine
US8329734B2 (en) 2009-07-27 2012-12-11 Afgin Pharma Llc Topical therapy for migraine
EP1435945B1 (en) * 2001-06-05 2008-08-13 Aung-din, Ronald Topical migraine therapy
EP1575566B1 (en) 2002-12-26 2012-02-22 Pozen, Inc. Multilayer dosage forms containing naproxen and triptans
WO2004112723A2 (en) 2003-06-20 2004-12-29 Ronald Aung-Din Tropical therapy for the treatment of migraines, muscle sprains, muscle spasm, spasticity and related conditions
AU2006338165B2 (en) * 2005-12-20 2010-10-28 Teikoku Pharma Usa, Inc. Methods of transdermally administering an indole serotonin receptor agonist and transdermal compositions for use in the same
CA2650412C (en) * 2006-04-13 2016-09-27 Nupathe, Inc. Transdermal methods and systems for the delivery of anti-migraine compounds
AU2009269129B2 (en) 2008-06-30 2015-08-20 Afgin Pharma, Llc Topical regional neuro-affective therapy
AU2010299607B2 (en) 2009-09-25 2016-07-28 Tonix Medicines, Inc. Formulations comprising triptan compounds
US11337962B2 (en) 2009-09-25 2022-05-24 Upsher-Smith Laboratories, Llc Formulations comprising triptan compounds
JP6216151B2 (en) * 2013-04-19 2017-10-18 コスメディ製薬株式会社 Hydrophilic drug emulsion patch
CN107530318A (en) 2015-03-02 2018-01-02 阿福金制药有限责任公司 Sex therapy is influenceed with the regional area nerve of cannboid
US10383816B2 (en) 2015-03-02 2019-08-20 Afgin Pharma, Llc Topical regional neuro-affective therapy with cannabinoid combination products
US20180049994A1 (en) 2016-08-16 2018-02-22 Afgin Pharma, Llc Topical regional neuro-affective therapy with caryophyllene

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3742951A (en) * 1971-08-09 1973-07-03 Alza Corp Bandage for controlled release of vasodilators
US3996934A (en) * 1971-08-09 1976-12-14 Alza Corporation Medical bandage
US5288498A (en) * 1985-05-01 1994-02-22 University Of Utah Research Foundation Compositions of oral nondissolvable matrixes for transmucosal administration of medicaments
GB2162522B (en) * 1984-08-01 1988-02-24 Glaxo Group Ltd An indole derivative
AU8072691A (en) * 1990-06-28 1992-01-23 Beecham Group Plc Pharmaceutical preparations
GB9103770D0 (en) * 1991-02-22 1991-04-10 Glaxo Group Ltd Chemical compounds
GB9104890D0 (en) * 1991-03-08 1991-04-24 Glaxo Group Ltd Compositions

Also Published As

Publication number Publication date
PL311591A1 (en) 1996-02-19
DE59408643D1 (en) 1999-09-23
NO954414L (en) 1995-11-03
CA2160776A1 (en) 1994-11-24
GR3031639T3 (en) 2000-02-29
WO1994026270A1 (en) 1994-11-24
FI955260A0 (en) 1995-11-02
ES2138659T3 (en) 2000-01-16
NO954414D0 (en) 1995-11-03
HUT74865A (en) 1997-02-28
JPH08509749A (en) 1996-10-15
CZ289395A3 (en) 1996-04-17
HU9503167D0 (en) 1996-01-29
ATE183392T1 (en) 1999-09-15
PL179353B1 (en) 2000-08-31
FI955260A (en) 1995-11-17
DE4314976C1 (en) 1994-10-06
KR960702306A (en) 1996-04-27
NZ265949A (en) 1997-10-24
EP0697869B1 (en) 1999-08-18
DK0697869T3 (en) 2000-03-20
SK138095A3 (en) 1996-06-05
IL109509A0 (en) 1994-08-26
AU686159B2 (en) 1998-02-05
EP0697869A1 (en) 1996-02-28
IL109509A (en) 1999-12-22
ZA942872B (en) 1995-07-06

Similar Documents

Publication Publication Date Title
AU6648094A (en) Transdermal therapeutic systems for the administration of serotonin agonists
AU3418993A (en) System for delivering an active substance for sustained release
DE69527509D1 (en) HYDROGEL FORMULATION WITH CONTROLLED RELEASE
AU6075198A (en) Drug delivery system for two or more active substances
AU4989997A (en) Soluble form osmotic dose delivery system
AU3136897A (en) Compositions, methods and devices for the transdermal delivery of drugs
AU7362496A (en) Dimer-selective rxr modulators and methods for their use
MX9706449A (en) Pharmaceutical composition for piperidinoalkanol compounds.
EP1382597A3 (en) Steroid receptor modulator compounds and methods
ZA9610729B (en) Transdermal device for the delivery of flurbiprofen.
AU6675198A (en) Transdermal drug delivery system for the administration of tamsulosin, and related compositions and methods of use
NZ236002A (en) Transdermal delivery system for 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazole
NO305906B1 (en) Adhesion receptor antagonists, pharmaceutical preparations containing such compounds, and the use of the compounds for the manufacture of drugs.
WO1997037640A3 (en) Uniform drug delivery therapy
MX9800408A (en) Cyclo-oxygenase inhibitor and amidine derivative salts, preparation method therefor, use thereof as drugs, and pharmaceutical compositions containing said salts.
AU5805096A (en) Transdermal therapeutic system (TTS) for the administration of testosterone
CA2317954A1 (en) Device for coating granules to be administered orally
AU5818096A (en) Topical aciclovir preparation
AU637861B2 (en) Improved system for the transdermal application of pharmacologically active compounds at controlled ph
CA2250844A1 (en) Anti-hiv composition comprising imidazole derivatives
SI0697869T1 (en) Transdermal therapeutic systems for the administration of serotonin agonists
AU1207292A (en) Halohydrocarbon-free timed-release coating solution for pharmaceutical preparations
EP1082958A3 (en) 5-HT1F agonists in chronic pain
NO931208L (en) FORMULATIONS FOR TRANSDERMAL CONTRASE OPTIVES, AND PROCEDURES AND DEVICES FOR SUPPLYING SUCH
CA2249637A1 (en) Uniform drug delivery therapy